Scientific work with Retatrutide may help evaluate how GIP receptor activity contributes to broader incretin and endocrine network behavior, especially when it occurs alongside GLP-1 and glucagon receptor engagement
A pivotal study published in the New England Journal of Medicine reported that participants who received the highest dose of Zepbound (15 mg) lost an average of 22.5% of their body weight after 72 weeks of treatment
If you link to a page for a compounded GLP-1 while writing about Ozempic specifically, you're going to get in trouble

Heidi Skolnik has written a timely and valuable resource that brings together evidence from multiple perspectives and makes an important contribution to advancing safe, effective GLP1 therapy in clinical practice.Heidi Prather DO, Hospital for Special Surgery and Professor at Cornell Medicine Heidi Skolnik has always had a gift for translating nutrition science into practical, approachable advice that people can actually use in their daily lives.Keri Glassman MS, RD, CDN, founder and president of Nutritious Life Your GLP-1 Game Plan makes it clear that medication is only one piece of the puzzlenutrition, movement, mindset, and daily habits are what help turn that prescription into lasting health. Heidi Skolnik brings clarity, compassion, and decades of trusted nutrition expertise to one of todays most important health conversations.Jamie Macdonald, General Manager, Plus One Health Management Your GLP-1 Game Plan is an overdue, practical guide that helps build sustainable habits for long-term success in this rapidly evolving field.

Factors such as Medicaid coverage, income levels, age, and healthcare infrastructure play a crucial role in determining who can currently benefit from these medications, and addressing these disparities will be key to maximizing access to GLP-1 therapies in the years ahead